Effectiveness of different therapy protocols in preemies with intestinal hypomotility

Area of Science:

• Neonatology
• Gastroenterology
• Pharmacology

Background:

• Intestinal hypomotility is a common issue in preterm infants, delaying crucial feeding milestones and stool normalization.
• Current management often involves interventions to stimulate bowel function.
• The efficacy of prokinetic agents in conjunction with enemas for improving intestinal motility in this population requires further investigation.

Purpose of the Study:

• To evaluate the effectiveness of adding erythromycin to enema therapy for preterm infants with intestinal hypomotility.
• To compare the time to achieve full enteral feeds and normal stooling patterns between different enema-based treatment protocols.
• To assess secondary outcomes including necrotizing enterocolitis and hospitalization length.

Main Methods:

• A randomized controlled trial was conducted with 67 preterm infants (≤32 gestational weeks) diagnosed with intestinal hypomotility.
• Infants were divided into two groups: Group 1 received daily saline enemas, and Group 2 received erythromycin plus enemas.
• A third historical control group (Group 3) received enemas only when clinically indicated.

Main Results:

• No significant difference was observed in the time to achieve full enteral feeds (25 vs. 26 days) or normal stooling patterns (18 vs. 15 days) between Group 1 and Group 2.
• Both Group 1 and Group 2 demonstrated significantly shorter times to achieve full enteral feeds and normal stooling compared to Group 3.
• Hospitalization length did not differ significantly across the groups.

Conclusions:

• The addition of erythromycin to enema therapy did not yield significant improvements in patient outcomes for preterm infants with intestinal hypomotility.
• Therapeutic protocols involving regular enemas (daily saline or erythromycin-assisted) were more effective than symptom-triggered enemas in managing intestinal hypomotility.
• Further research may be needed to explore alternative or adjunctive therapies for optimizing intestinal function in this vulnerable patient group.